Izotropic Corporation

🗞️ Izotropic Africa Launches Operations in Casablanca 🔗 izocorp.com/news-releases/…

Izotropic Corporation announces the official launch of Izotropic Africa in Casablanca, Morocco, expanding regional operations across Africa and GCC markets. Led by Mohammed Sair, this milestone supports planned commercialization efforts for IzoView and the Company’s mission to advance breast imaging technology. Link: izocorp.com/news-releases/…

Early-onset breast cancer: a survivor’s story dlvr.it/TPPGKV #Conditions #OncologyHematology via @kevinmd

Addressing a Critical Global Health Need Breast cancer is the most prevalent cancer among African women, with mortality rates exceeding 50% due to delayed diagnosis. Izotropic is taking a bold step to change this narrative. By establishing Izotropic Africa in Casablanca, Morocco, we are positioning our IzoView Breast CT technology at the heart of a region projected to have a $500M+ market for advanced oncology devices by 2030. Morocco will serve as $IZO.c strategic gateway, bridging the gap to underserved markets across Africa and the GCC. The mission is clear: provide the advanced imaging necessary to lower mortality rates and improve patient outcomes where it is needed most.

The Roadmap to Commercialization - Izotropic Africa Partnership Details Following the recent Letter Agreement, Izotropic Corporation $IZOZF is moving swiftly on our regional roadmap. Key operational milestones include: Clinical Foundation: A major hospital site in Morocco is being secured in Q1 2026 for the first IzoView Breast CT installation to drive research and regulatory approvals. Structure: A joint venture (60% BG / 40% Izotropic) designed to scale sales, marketing, and potential regional manufacturing. Timeline: Parties are working in good faith to finalize a Formal Agreement by the region's regulatory landscape and establish a manufacturing foothold Commitment: Izotropic has committed an initial $30K (of an estimated $120K first-year share) to jumpstart operations and clinical data collection. This partnership combines Izotropic’s technical innovation with local expertise to navigate regulatory landscapes and establish a manufacturing foothold in the region. LINK: izocorp.com/news-releases/…

Izotropic Corp. Expands Global Footprint into Africa and Middle East Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) is pleased to announce it has signed a Letter Agreement to establish Izotropic Africa, a new entity based in Casablanca, Morocco. Partnering with an established business group, this strategic move aims to bring IzoView Breast CT technology to two high-growth regions: all of Africa and the Gulf Cooperation Council (GCC)- including Saudi Arabia, the UAE, Qatar, Kuwait, Bahrain, and Oman.

“The Company’s primary objective is securing capital financing… efforts may include the investigation and continued development of strategic relationships that have advanced to due diligence stages, with the objective of executing letters of intent and definitive agreements. Such arrangements may include the formation and advancement of global business units, territory and manufacturing rights, master distribution agreements, and the management of accelerated regulatory procedures and approvals in additional markets.”

Check out our FAQ here: buff.ly/7l1pmH7

Is IzoView Breast CT the same as digital breast tomosynthesis or 3D mammography? No, digital breast tomosynthesis ("DBT"), also known as 3D mammography, is a limited-angle imaging technique. It uses a short arc of x-ray projections (15° to 50°), still with compression. IzoView performs a full 360° scan, generating real 3D volumetric images without compression, for more clarity, especially in dense breasts. #FAQ #Technology #Education #HowStuffWorks #Izotropic #IzoView #BreastCT #BreastCancer #MedicalDevices #MedTech #WomensHealth #Innovation $IZO $IZOZF IzoView is not yet approved for sale.

Learn more about the IzoView innovation at izocorp.com

Why does Izotropic exist? It’s not just about engineering; it’s about making a real-world impact on women’s health. In this interview, we explore how Izotropic takes academic know-how and transforms it into commercially viable solutions like IzoView, driven by a purpose to serve patients and families. #BreastCancer #EarlyDetectionSavesLives #BreastDensity #WomensHealth #MedTechNews #HealthEducation #Radiology #MedicalDevices #MedicalImaging #Radiology #BreastCancerAwareness #HealthTech #DigitalHealth #IzoView #Izotropic $IZO $IZOZF This video features AI-generated avatars. The audio and dialogue are authentic recordings from a live interview. IzoView is not yet approved for sale.

Check out our technology presentation at: buff.ly/dL37Qv6

How does IzoView Breast CT differ from mammography? Mammography is a 2D imaging method that compresses the breast to capture X-ray images. This approach has limitations, particularly in women with dense breast tissue, where overlapping structures can hide tumors. IzoView eliminates compression and provides true 3D imaging using a 360-degree rotation around the breast, capturing fine anatomical detail that mammography can miss. #FAQ #Technology #Education #HowStuffWorks #Izotropic #IzoView #BreastCT #BreastCancer #MedicalDevices #MedTech #WomensHealth #Innovation $IZO $IZOZF IzoView is not yet approved for sale.

See our three key takeaways and what is means for Izotropic at: breastct.com/breast-imaging…

Experts continue to highlight gaps in conventional 2D mammography—especially around breast density, a major barrier to accurate screening. IzoView Breast CT was engineered to overcome these limitations with true 3D, high-resolution volumetric imaging and a patented method for measuring breast density. As screening strategies evolve toward more accurate, volumetric approaches, IzoView is strongly positioned to meet this unmet need. #BreastCancer #EarlyDetectionSavesLives #BreastDensity #WomensHealth #MedTechNews #HealthEducation #rRadiology #MedicalDevices #CEMark #RegulatoryStrategy #MedicalImaging #Radiology #BreastCancerAwareness #HealthTech #DigitalHealth #AIinHealthcare #IzoView #Izotropic #InvestorNews #BioTech #stocktowatch $IZO $IZOZF IzoView is not yet approved for sale.

If Breast CT is optimal for breast imaging, why is mammography still the standard? In this clip, we explore the evolution of breast imaging. While acknowledging mammography's role in saving lives, we discuss its critical limitations with dense breast tissue. Learn how the industry is already moving toward "pseudo 3D" with Digital Breast Tomosynthesis and why Izotropic believes 360-degree imaging is the inevitable future! #BreastCancer #EarlyDetectionSavesLives #BreastDensity #WomensHealth #MedTechNews #HealthEducation #Radiology #MedicalDevices #MedicalImaging #Radiology #BreastCancerAwareness #HealthTech #DigitalHealth #IzoView #Izotropic $IZO $IZOZF This video features AI-generated avatars. The audio and dialogue are authentic recordings from a live interview. IzoView is not yet approved for sale.

See our three key takeaways and what is means for Izotropic at: breastct.com/breast-imaging…

Even with advances like CEM and DBT, reductions in false positives remain modest—reinforcing the limits of compression-based imaging. Researchers are now combining two compression-dependent modalities to overcome challenges created by tissue overlap. IzoView Breast CT takes a different approach: true 3D, non-compressed imaging that removes tissue overlap entirely and supports more confident, accurate cancer detection. #BreastCancer #EarlyDetectionSavesLives #BreastDensity #WomensHealth #MedTechNews #HealthEducation #rRadiology #MedicalDevices #CEMark #RegulatoryStrategy #MedicalImaging #Radiology #BreastCancerAwareness #HealthTech #DigitalHealth #AIinHealthcare #IzoView #Izotropic #InvestorNews #BioTech #stocktowatch $IZO $IZOZF IzoView is not yet approved for sale.

As 2025 comes to a close, we’re grateful for the community that surrounds us— clinicians, researchers, advocates, collaborators, and investors—who support our mission to advance breast imaging through innovation. Thank you for being part of the journey. From our team to yours, we wish you a peaceful, joyful holiday season and a healthy New Year. — The Izotropic Team

See our three key takeaways and what is means for Izotropic at: breastct.com/breast-imaging…

New data showing more invasive breast cancers in younger women strengthens the shift toward risk-adapted screening. With patented 3D breast-density measurement and true 3D imaging, IzoView Breast CT can help establish earlier baseline assessments and support personalized screening pathways. #BreastCancer #EarlyDetectionSavesLives #BreastDensity #WomensHealth #MedTechNews #HealthEducation #rRadiology #MedicalDevices #CEMark #RegulatoryStrategy #MedicalImaging #Radiology #BreastCancerAwareness #HealthTech #DigitalHealth #AIinHealthcare #IzoView #Izotropic #InvestorNews #BioTech #stocktowatch $IZO $IZOZF IzoView is not yet approved for sale.